Related Experiment Videos
A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II
T H Ottenhoff1, A Geluk, M Toebes
1Department of Immunohematology and Blood Bank, Leiden University Hospital, Netherlands. ihbsecr@euronet.nl
Journal of Immunological Methods
|January 15, 1997
Summary
A new, automated assay accurately measures peptide binding to HLA molecules. This sensitive and reproducible method uses fluorescence detection and is suitable for high-throughput screening of peptide-HLA interactions.
Area of Science:
- Immunology
- Biochemistry
- Analytical Chemistry
Background:
- Accurate measurement of peptide-HLA binding is crucial for understanding immune responses and developing vaccines or immunotherapies.
- Existing methods for assessing peptide-HLA interactions can be labor-intensive, time-consuming, or require specialized equipment.
Purpose of the Study:
- To develop and validate a sensitive, reproducible, and automated assay for quantifying peptide binding to Human Leukocyte Antigen (HLA) class I and II molecules.
- To establish a high-throughput compatible method for characterizing peptide-HLA binding affinities.
Main Methods:
- A competitive binding assay utilizing a fluorescently labeled standard peptide and the peptide of interest.
- Equilibrium binding of peptides to purified HLA molecules, followed by separation using HPLC size-exclusion chromatography.
- On-line fluorescence detection of bound and free peptides, with automated data analysis to determine IC50 values.
Main Results:
- The assay demonstrated high sensitivity and reproducibility across different HLA alleles (e.g., HLA-DR1, -DR17, -A*0201, -A*0301).
- The method requires minimal amounts of labeled peptide (100 fmol) and HLA (10 pmol).
- Automated sample handling and data processing enabled a typical analysis time of 10-12 minutes per sample.
Conclusions:
- The developed assay is a robust, non-radioactive, and non-labor-intensive tool for measuring peptide-HLA binding.
- Its high degree of automation and sensitivity make it suitable for large-scale screening in immunological research and drug discovery.